金年会

About Henlius

Company Profile

Corporate Culture

Honor

Management Team

Board of Directors
Product

Marketed Products

Products in R&D

Clinical Trial
Science & Technology

R&D Result

Innovation Canter

Technology Platform

Quality Management

Manufacturing

Collaborations
Investor Relations

Information Disclosure

Corporate Governance

Financial Reports

Stock Info

IR Calendar

Investor Presentation

Analyst Coverage

Contact Information
Media

Press Release

Multi-media

Media Reports

Media Enquiry
Careers

Talent Philosophy

Staff Life

Training and Development

Job Opportunities
Contact Us

Contact Information

Customer Message

Privacy

Legal Statement

Compliance

EN

简体
EN
繁體

Company Profile
Corporate Culture
Honor
Management Team
Board of Directors

Marketed Products
Products in R&D
Clinical Trial

Science & Technology

R&D Result
Innovation Canter
Technology Platform
Quality Management
Manufacturing
Collaborations

Investor Relations

Information Disclosure
Listing Documents Announcement & Circulars
Corporate Governance
Financial Reports
Stock Info
IR Calendar
Investor Presentation
Analyst Coverage
Contact Information

Press Release
2022 2021 2020 2019 2018 2017 2016 2015 2014
Multi-media
Company Event Popular Science
Media Reports
Media Enquiry

Talent Philosophy
Staff Life
Training and Development
Job Opportunities

Contact Information
Customer Message
Privacy
Legal Statement
Compliance

Technical Innovation Operational Excellence

Information Disclosure
Announcement & Circulars Listing Documents
Corporate Governance
Board of Directors Committees Others
Reporting
Financial Reports ESG Report
Stock Info
IR Calendar
Investor Presentation
Analyst Coverage
Contact Information

Investor Presentation

18 August 2022

Henlius 1H22 Results Investor Presentation
16 March 2022

Henlius 2021 Annual Results
18 August 2021

Henlius 1H21 Results Investor Presentation
26 March 2021

Henlius 2020 Annual Results
30 September 2020

Henlius Recent Business Update
24 August 2020

Henlius 1H20 Results Investor Presentation
13 June 2020

Henlius Global R&D Day
24 April 2020

Henlius HLX02(trastuzumab) EU GMP approval

About Henlius: Company Profile; Corporate Culture; Honor; Management Team; Board of Directors

Product: Marketed Products; Products in R&D; Clinical Trial

Science & Technology: R&D Result; Innovation Canter; Technology Platform; Quality Management; Manufacturing; Collaborations

Investor Relations: Information Disclosure; Corporate Governance; Financial Reports; Stock Info; IR Calendar; Investor Presentation; Analyst Coverage; Contact Information

Media: Press Release; Multi-media; Media Reports; Media Enquiry

Careers: Talent Philosophy; Staff Life; Training and Development; Job Opportunities

Contact Us: Contact Information; Customer Message; Privacy; Legal Statement; Compliance; Adverse Drug Event Reporting

Copyright © 2019 Shanghai Henlius Biotech, Inc. All rights reserved.
沪ICP备23029242号-2

沪公网安备 31818482882777号
Internet Drug Information Service Certification Number: (Shanghai) non-commercial- 2019-0049

Linkedin

WeChat